Hemodialysis

Rockwell Medical, Inc. Announces Presentations at the American Society of Nephrology Virtual Kidney Week 2020

Retrieved on: 
Tuesday, October 13, 2020
Membrane technology, Medicine, Clinical medicine, Physical sciences, Renal dialysis, Rockwell Medical, Kidney diseases, Organ failure, Hemodialysis, Chronic kidney disease, Dialysis, Iron(III) pyrophosphate

The Companys initial focus is the treatment of anemia in end-stage kidney disease (ESKD).

Key Points: 
  • The Companys initial focus is the treatment of anemia in end-stage kidney disease (ESKD).
  • Rockwell Medical's exclusive renal drug therapies, Triferic (ferric pyrophosphate citrate) Dialysate and Triferic AVNU, are the only FDA-approved therapeutics indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients.
  • Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad.
  • Triferic is a registered trademark of Rockwell Medical, Inc. Triferic AVNU is pending with the U.S. Patent and Trademark Office.

Worldwide Industry for Hemodialysis Catheters and Dialyzers to 2024 - Featuring B Braun, Baxter and Bellco Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 8, 2020
Medical devices, Health, Business process, Catheters, Hemodialysis, Membrane technology, Renal dialysis, Medical device, Dialysis catheter, Market analysis

The "Global Hemodialysis Catheters and Dialyzers Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hemodialysis Catheters and Dialyzers Market" report has been added to ResearchAndMarkets.com's offering.
  • This report was developed using extensive primary and secondary research by the publisher's analysts.
  • Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share for the top suppliers by product segment.
  • Devices in this global market analysis include hemodialysis catheters, cannulae and dialyzers.

Microbot Medical Receives Notice of Allowance for U.S. Patent Covering a System for Reducing Dialysis Shunt Stenosis

Retrieved on: 
Wednesday, October 7, 2020
Membrane technology, Medicine, Renal dialysis, Hemodialysis, Dialysis

15/592,227, which pertains to a device for reducing dialysis shunt stenosis.

Key Points: 
  • 15/592,227, which pertains to a device for reducing dialysis shunt stenosis.
  • This latest patent allowance demonstrates the continued solid execution of our IP portfolio strategy, commented Harel Gadot, Chief Executive Officer, President and Chairman.
  • The allowed patent application covers a system for reducing venous stenosis associated with the use of hemodialysis shunts.
  • Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

Retrieved on: 
Thursday, September 17, 2020
Biotechnology, Hospitals, Health, Medical Supplies, Medicine, Clinical medicine, Membrane technology, Renal dialysis, Dialysis, Hemodialysis, Home hemodialysis

View the full release here: https://www.businesswire.com/news/home/20200916005511/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200916005511/en/
    Fresenius Medical Care today announced the launch of the organizations first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific.
  • We have chosen World Patient Safety Day to highlight the importance of this issue.
  • These will begin with an online symposium presented on World Patient Safety Day, Does Ultrapure Dialysis Fluid Matter in Hemodialysis?
  • For more information about Ultrapure Dialysis Fluid, please visit: https://bit.ly/3moMk0Q
    The online symposium Does Ultrapure Dialysis Fluid Matter in Hemodialysis?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Retrieved on: 
Tuesday, September 15, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Natural sciences, Haemo, Quanta, Dialysis, Home hemodialysis, Hemodialysis, Medtech, ALCESTER

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Retrieved on: 
Tuesday, September 15, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Natural sciences, Haemo, Quanta, Dialysis, Home hemodialysis, Hemodialysis, Medtech, ALCESTER

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Ellipsys System Offers Greater Patient Eligibility and Reduced Time to Dialysis

Retrieved on: 
Thursday, September 10, 2020
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Vascular access, Hemodialysis, Fistula, Arteriovenous fistula, Dialysis, Catheter, Cimino fistula, Interventional radiology

The Ellipsys System had a technical success rate of 100 percent, and only 27.7 percent of patients required secondary interventions following fistula creation.

Key Points: 
  • The Ellipsys System had a technical success rate of 100 percent, and only 27.7 percent of patients required secondary interventions following fistula creation.
  • Overall, 79.5 percent of Ellipsys patients and 58 percent of WavelinQ patients were able to successfully begin dialysis with their fistula.
  • "For every patient, my goal is to create the best possible dialysis access with the fewest possible interventions," said Dr. Shahverdyan.
  • The company's Ellipsys Vascular Access System is an innovative, ultrasound-guided, single-catheter endoAVF system used to percutaneously create an arteriovenous fistula for hemodialysis access.

Rockwell Medical to Host Conference Call and Webcast with Management and Key Opinion Leaders to Discuss Potential Novel Indications for Its FPC Platform

Retrieved on: 
Wednesday, September 9, 2020
Medicine, Membrane technology, Renal dialysis, Rockwell Medical, Hemodialysis, Medical school, Dialysis

The call and webcast will include representatives from Rockwell Medical as well as key opinion leaders (KOLs) Connie Sullivan, B.S.

Key Points: 
  • The call and webcast will include representatives from Rockwell Medical as well as key opinion leaders (KOLs) Connie Sullivan, B.S.
  • (Oxon), Emeritus Professor of Medicine at the University of Minnesota Medical School and Former Director of the Heart Failure Program at VA Medical Center in Minneapolis.
  • "My charge as CEO is to actualize the potential of our FPC technology, for patients and for shareholders, said Russell Ellison, M.D., M.Sc., President and Chief Executive Officer of Rockwell Medical.
  • I believe there is potential for important value creation through the development of the FPC platform to treat medical conditions with unmet clinical needs outside of the hemodialysis setting.

Global Hemodialysis Catheters Market (2020 to 2024) - Featuring Cook Group, Medtronic & Nipro Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 9, 2020
Medical devices, Health, Catheter, Hemodialysis, Dialysis catheter

The global hemodialysis catheters market is poised to grow by $190 million during 2020-2024, progressing at a CAGR of 5% during the forecast period.

Key Points: 
  • The global hemodialysis catheters market is poised to grow by $190 million during 2020-2024, progressing at a CAGR of 5% during the forecast period.
  • This report on the hemodialysis catheters market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • This study identifies the advances in technology as one of the prime reasons driving the hemodialysis catheters market growth during the next few years.

Global Hemodialysis Catheters Market 2020-2024: COVID-19 Business Continuity Plan | Evolving Opportunities with AngioDynamics Inc. and B. Braun Melsungen AG | Technavio

Retrieved on: 
Tuesday, September 8, 2020
Medical devices, Health, Medicine, Clinical medicine, Catheters, Membrane technology, Renal dialysis, Hemodialysis, Dialysis catheter, B. Braun, Port, Dialysis, Braun

View the full release here: https://www.businesswire.com/news/home/20200908005667/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200908005667/en/
    Technavio has announced its latest market research report titled Global Hemodialysis Catheters Market 2020-2024 (Graphic: Business Wire)
    Read the 120-page report with TOC on "Hemodialysis Catheters Market Analysis Report by Product (Long-term hemodialysis catheters and Short-term hemodialysis catheters) and Geography (North America, Europe, APAC, and ROW), and the Segment Forecasts, 2020-2024".
  • In addition, the advances in technology are anticipated to boost the growth of the Hemodialysis Catheters Market.
  • The growing prevalence of CKD is expected to increase the demand for dialysis catheters, especially hemodialysis catheters globally.
  • B. Braun Melsungen AG has business operations under various segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum.